Company Quick10K Filing
Idexx Laboratories
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-04-30
10-K 2019-12-31 Filed 2020-02-14
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-31 Filed 2019-02-15
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-02-16
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-04-28
10-K 2016-12-31 Filed 2017-02-17
10-Q 2016-09-30 Filed 2016-11-01
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-02-17
10-Q 2015-09-30 Filed 2015-10-28
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-04-28
10-K 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-10-24
10-Q 2014-06-30 Filed 2014-07-25
10-Q 2014-03-31 Filed 2014-04-25
10-K 2013-12-31 Filed 2014-02-18
10-Q 2013-09-30 Filed 2013-10-22
10-Q 2013-06-30 Filed 2013-07-23
10-Q 2013-03-31 Filed 2013-04-23
10-K 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-10-19
10-Q 2012-06-30 Filed 2012-07-20
10-Q 2012-03-31 Filed 2012-04-20
10-K 2011-12-31 Filed 2012-02-17
10-Q 2011-09-30 Filed 2011-10-21
10-Q 2011-06-30 Filed 2011-07-22
10-Q 2011-03-31 Filed 2011-04-21
10-K 2010-12-31 Filed 2011-02-22
10-Q 2010-09-30 Filed 2010-10-22
10-Q 2010-06-30 Filed 2010-07-23
10-Q 2010-03-31 Filed 2010-04-23
10-K 2009-12-31 Filed 2010-02-19
8-K 2020-07-31 Earnings, Exhibits
8-K 2020-05-06
8-K 2020-04-30
8-K 2020-04-10
8-K 2020-04-02
8-K 2020-03-23
8-K 2020-01-31
8-K 2019-10-31
8-K 2019-10-23
8-K 2019-08-05
8-K 2019-08-01
8-K 2019-07-24
8-K 2019-07-16
8-K 2019-06-28
8-K 2019-05-08
8-K 2019-05-01
8-K 2019-03-14
8-K 2019-02-01
8-K 2018-11-01
8-K 2018-08-01
8-K 2018-06-13
8-K 2018-05-09
8-K 2018-05-04
8-K 2018-02-14
8-K 2018-02-01
8-K 2018-01-05

Idexx Laboratories Financials

IDXX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Idexx Laboratories (IDXX) 24,091 57% 39.6 25% 1,751 1,549 2,351 1,335 440 605 23,987
Neogen (NEOG) 3,449 46% 38.2 8% 751 60 422 196 61 89 3,383
Immunomedics (IMMU) 2,749 -8.6 -78% 412 388 0 0 -322 -278 2,383
Quidel (QDEL) 2,603 60% 22.6 9% 868 333 515 308 75 114 2,574
Myriad Genetics (MYGN) 2,118 0% 31.0 -1% 1,591 517 835 0 -15 73 2,255
Lantheus Holdings (LNTH) 1,051 51% 28.3 3% 402 301 344 174 13 41 1,170
Intellia Therapeutics (NTLA) 669 80% -7.3 -26% 347 71 40 32 -90 -86 631
Quotient (QTNT) 549 45% -6.7 -58% 177 224 31 14 -103 -92 621
Oxford Immunotec Global (OXFD) 463 72% -196.4 -0% 239 24 56 40 -0 -1 279
Meridian Bioscience (VIVO) 418 59% 9.9 7% 325 135 201 118 24 43 432
Volitionrx (VNRX) 242 0% -18.8 -53% 24 6 0 0 -13 -12 225
Trinity Biotech (TRIB) 235 0% 152 108 0 0 0 0 228
Oncocyte (OCX) 107 -6.1 -44% 33 3 0 0 -14 -14 87
Nymox Pharmaceutical (NYMX) 92 0% 8 1 0 0 0 0 92
Vermillion (VRML) 51 21% -3.2 -72% 17 5 3 1 -12 -12 37
Immucell (ICCC) 48 49% 62.0 -3% 39 10 10 5 -1 1 47
Riot Blockchain (RIOT) 42 20% -1.6 -50% 33 5 6 1 -17 -16 26
Celldex Therapeutics (CLDX) 40 0% 17.3 0% 132 30 4 0 0 1 23
Achieve Life Sciences (ACHV) 17 -0.6 -147% 11 3 0 0 -17 -17 10
Navidea Biopharmaceuticals (NAVB) 13 99% -1.3 -170% 5 5 1 1 -8 -8 10

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash118134157153159181184185202221224228251265279286305293323182163141129133141150155160166169188159175147124117111104
Accounts Receivable127120120138149135141161147141138159159152158180169160152196199191188212212205204225240228235260265265249281286268
Inventory122132128127134137133141144147141148141146133141145156160173184192189184176168158172170177164179176180173189197205
PP&E197201202203210214422217221232478254266274550282287292604310326320679343347350743361365368812384394410906449470497
Assets8348628979099519691,0311,0611,0671,0931,1041,1331,1641,1951,2311,2621,2831,2911,3841,4311,4771,4771,4751,4791,4891,5001,5311,5721,6371,6691,7131,4691,5211,5451,5371,6811,7241,751
Accounts Payable2325232330313741303235393838304341584544585453525044606259616770686570706876
Long-Term Debt33151367597610632607
Liabilities3093163233133423834914944774764675016146607127508301,0611,2671,3971,4691,5161,5591,5521,4981,4451,6391,6461,7231,7181,7671,5181,5621,5461,5471,6291,5531,549
Stockholders' Equity524547574597609586540567590618636631550535518512453229118348-39-84-74-955-108-74-86-49-54-49-41-2-1052171202
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue281270188293318301307323336315320332353338354360412384352382413406400418467448443462509492506538581545549576620605
Cost of Revenue1321271391381541421481481571451501481581531651581771701701671811828919020620296204216218234235248240249244262260
Gross Profit149142145155187159159175201171169184211186189202235213182216233224218228261247241258293274272303332306300332358345
R&D17171718191920212120212224222223272525252425252525262526272829293029323234
SG&A7775768493838394998785101110101105109120116122118120119125129131133131140143146146161157159167161171
Tax1715141724171719262020162419172126164202521152030252516292251152916223024
Net Income37353637513938415443434556464347585226475744444667565269857138891099386103143109
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating554925637557156475772179806634829327-15807423111100100311101111213511911134137132
Cash Investing-11-14-6-16-16-58-7-15-19-25-17-24-27-18-13-9-23-36-161-67-26-24-30-23-14-29-44-41-24260-28-54-38-34-37
Cash Financing-32-11-23-42-374-7-32-37-502-31-40-33-15-55-764237-34-591-73-69-771-63-68-78-325-71-84-3-109-100